PATENT CLAIM ANALYSIS

Application Number: 16162170
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["424", "204100"]

Abstract:
The present invention provides a recombinant influenza virus vector comprising an NS gene encoding a truncated NS1 protein of at least 73 and up to 122 amino acids of the N-terminus of the respective wild type NS1 protein, wherein the vector replicates in IFN-sensitive tumor cells and does not replicate in normal, non-tumor cells, and expresses a heterologous immunostimulatory polypetide. The invention further provides a pharmaceutical composition containing the influenza virus vector, its use for the treatment of cancer patients and methods for producing the influenza virus vaccine.

Claim (Index 9):
The influenza virus vector of  claim 1 , wherein the vector comprises modifications of the genes encoding the NA and/or HA proteins.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 97.0
- Lexical Diversity: 1.51613
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15031715', '14049601', '15375664', '16126791', '12148798']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.710416200667966
- 35 USC 102 Novelty (BERT): 0.6386680603833247
- Combined Prediction Score: 0.7032413866395019
- Mean Citation Score: 409.569488
- Max Citation Score: 591.21484
- Similarity Product: 557.9969366716242

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test